Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Sara Ravaioli"'
Autor:
Martine Bocchini, Marcella Tazzari, Sara Ravaioli, Filippo Piccinini, Flavia Foca, Michela Tebaldi, Fabio Nicolini, Ilaria Grassi, Stefano Severi, Raffaele Adolfo Calogero, Maddalena Arigoni, Joerg Schrader, Massimiliano Mazza, Giovanni Paganelli
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) are rare diseases encompassing pancreatic (PanNETs) and ileal NETs (SINETs), characterized by heterogeneous somatostatin receptors (SSTRs) expression. Treatments for inoperable GEP-NETs are li
Externí odkaz:
https://doaj.org/article/e7851a614d4d443b97fb8a0ee8e2f70d
Autor:
Francesca Pirini, Michela Cortesi, Maria Maddalena Tumedei, Michele Zanoni, Sara Ravaioli, Sara Bravaccini
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2023)
The role of the intestinal microbiota in the promotion, progression, and response to therapies is gaining importance, but recent studies confirm the presence of microbiota also in the tumor, thus becoming a component of the tumor microenvironment. Th
Externí odkaz:
https://doaj.org/article/10c53cf28db24a9fa541ac26dc8f12bc
Autor:
Sara Bravaccini, Fabio Nicolini, Michele Zanoni, Anna Gaimari, Claudio Cerchione, Roberta Maltoni, Francesca Pirini, Lucia Mazzotti, Michela Cortesi, Sara Ravaioli, Maria Maddalena Tumedei, Massimiliano Mazza
Publikováno v:
Translational Oncology, Vol 26, Iss , Pp 101541- (2022)
Zhang et al. reported the impact of different risk factors and comorbidities in COVID-19 lethality. The authors observed that the odds of dying by COVID-19 in cancer patients decrease with age and cancer becomes a non-significant factor above 80 year
Externí odkaz:
https://doaj.org/article/5f27b11055b943d494e3bc8c52f95648
Autor:
Sara Ravaioli, Roberta Maltoni, Barbara Pasculli, Paola Parrella, Anna Maria Giudetti, Daniele Vergara, Maria Maddalena Tumedei, Francesca Pirini, Sara Bravaccini
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Androgen receptor (AR) is expressed in 60-70% of breast cancers (BCs) and the availability of anti-AR compounds, currently used for treating prostate cancer, paves the way to tackle specifically AR-positive BC patients. The prognostic and predictive
Externí odkaz:
https://doaj.org/article/b67955f818b24cc7a58287a220eb2ff7
Autor:
Maria Maddalena Tumedei, Sara Ravaioli, Federica Matteucci, Monica Celli, Ugo De Giorgi, Roberta Gunelli, Maurizio Puccetti, Giovanni Paganelli, Sara Bravaccini
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Bladder cancer (BCa) patients are diagnosed by cytology and cystoscopy. However, these diagnostic tests bear some limitations. We sought for reliable biomarkers to better determine BCa extension. Prostate-specific membrane antigen (PSMA) app
Externí odkaz:
https://doaj.org/article/9e48e4bb4424421c8efc0070bd91a8d6
Autor:
Andrea Fontana, Raffaela Barbano, Elisa Dama, Barbara Pasculli, Michelina Rendina, Maria Grazia Morritti, Valentina Melocchi, Marina Castelvetere, Vanna Maria Valori, Sara Ravaioli, Sara Bravaccini, Luigi Ciuffreda, Paolo Graziano, Evaristo Maiello, Massimiliano Copetti, Vito Michele Fazio, Manel Esteller, Fabrizio Bianchi, Paola Parrella
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract While the molecular functions of miR-200 family have been deeply investigated, a role for these miRNAs as breast cancer biomarkers remains largely unexplored. In the attempt to clarify this, we profiled the miR-200 family members expression
Externí odkaz:
https://doaj.org/article/7f115660f6094fd1a43b8c2f4d61692a
Autor:
Roberta Maltoni, Sara Ravaioli, Giuseppe Bronte, Massimiliano Mazza, Claudio Cerchione, Ilaria Massa, William Balzi, Michela Cortesi, Michele Zanoni, Sara Bravaccini
Publikováno v:
Translational Oncology, Vol 15, Iss 1, Pp 101300- (2022)
Ma and colleagues reported in their study on 12,004 elderly patients published on Breast J. 2020, that adjuvant chemotherapy was not associated with overall survival. Given the toxicities associated with systemic treatments, caution recommendation or
Externí odkaz:
https://doaj.org/article/48243069127b4c598fed7ca309fde0fd
Autor:
Sara Bravaccini, Giuseppe Bronte, Elisabetta Petracci, Maurizio Puccetti, Manolo D’Arcangelo, Sara Ravaioli, Maria Maddalena Tumedei, Roberta Maltoni, Angelo Delmonte, Federico Cappuzzo, Lucio Crinò
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Programmed death ligand 1 (PD-L1) is an immune checkpoint with a role in cancer-related immune evasion. It is a target for cancer immunotherapy and its expression is detected for the use of some immune checkpoint inhibitors in advanced non-small cell
Externí odkaz:
https://doaj.org/article/db302667216f4985b2e27f223631df39
Autor:
Giuseppe Bronte, Maurizio Puccetti, Elisabetta Petracci, Lorenza Landi, Paola Cravero, Simona Scodes, Paola Ulivi, Sara Ravaioli, Maria Maddalena Tumedei, Marco Angelo Burgio, Federico Cappuzzo, Angelo Delmonte, Lucio Crinò, Sara Bravaccini
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundCurrent therapy for non-small-cell lung cancer (NSCLC) frequently includes immune checkpoint inhibitors, such as pembrolizumab, and programmed death ligand 1 (PD-L1) positivity is mandatory for its use in this setting. Vimentin plays a role
Externí odkaz:
https://doaj.org/article/4aab8982f9c94ec6b69779244776a929
Autor:
Sara Ravaioli, Michela Tebaldi, Eugenio Fonzi, Davide Angeli, Massimiliano Mazza, Fabio Nicolini, Alessandro Lucchesi, Francesca Fanini, Francesca Pirini, Maria Maddalena Tumedei, Claudio Cerchione, Pierluigi Viale, Vittorio Sambri, Giovanni Martinelli, Sara Bravaccini
Publikováno v:
Cell Transplantation, Vol 29 (2020)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. One open question is whether genetics could influence the severity of symptoms. Considering the limited data on cancer patients, we analyzed public data reposi
Externí odkaz:
https://doaj.org/article/346e6e7766864bb8a06bb0a4bdf40a9c